{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:33:00Z","timestamp":1790976780113,"version":"4.1.0"},"reference-count":186,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>In the past 20 years, myostatin, a negative regulator of muscle mass, has attracted attention as a potential therapeutic target in muscular dystrophies and other conditions. Preclinical studies have shown potential for increasing muscular mass and ameliorating the pathological features of dystrophic muscle by the inhibition of myostatin in various ways. However, hardly any clinical trials have proven to translate the promising results from the animal models into patient populations. We present the background for myostatin regulation, clinical and preclinical results and discuss why translation from animal models to patients is difficult. Based on this, we put the clinical relevance of future antimyostatin treatment into perspective.<\/jats:p>","DOI":"10.3390\/cells10030533","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T05:10:16Z","timestamp":1614748216000},"page":"533","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Antimyostatin Treatment in Health and Disease: The Story of Great Expectations and Limited Success"],"prefix":"10.3390","volume":"10","author":[{"given":"Tue L.","family":"Nielsen","sequence":"first","affiliation":[{"name":"Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[{"name":"Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9330-668X","authenticated-orcid":false,"given":"Thomas O.","family":"Krag","sequence":"additional","affiliation":[{"name":"Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of Skeletal Muscle Mass in Mice by a New TGF-p Superfamily Member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/ng0997-71","article-title":"A Deletion in the Bovine Myostatin Gene Causes the Double-Muscled Phenotype in Cattle","volume":"17","author":"Grobet","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1101\/gr.7.9.910","article-title":"Mutations in Myostatin (GDF8) in Double-Muscled Belgian Blue and Piedmontese Cattle","volume":"7","author":"Kambadur","year":"1997","journal-title":"Genome Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"12457","DOI":"10.1073\/pnas.94.23.12457","article-title":"Double Muscling in Cattle Due to Mutations in the Myostatin Gene","volume":"94","author":"McPherron","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mosher, D.S., Quignon, P., Bustamante, C.D., Sutter, N.B., Mellersh, C.S., Parker, H.G., and Ostrander, E.A. (2007). A Mutation in the Myostatin Gene Increases Muscle Mass and Enhances Racing Performance in Heterozygote Dogs. PLoS Genet., 3.","DOI":"10.1371\/journal.pgen.0030079"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/acel.12339","article-title":"Haploinsufficiency of Myostatin Protects against Aging-Related Declines in Muscle Function and Enhances the Longevity of Mice","volume":"14","author":"Mendias","year":"2015","journal-title":"Aging Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1474-9726.2009.00508.x","article-title":"Effects of Myostatin Deletion in Aging Mice","volume":"8","author":"Morissette","year":"2009","journal-title":"Aging Cell"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Xiao, J. (2018). Past, Present, and Future Perspective of Targeting Myostatin and Related Signaling Pathways to Counteract Muscle Atrophy. Muscle Atrophy, Springer. Advances in Experimental Medicine and Biology.","DOI":"10.1007\/978-981-13-1435-3"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/iub.1392","article-title":"Myostatin: Expanding Horizons: Myostatin","volume":"67","author":"Sharma","year":"2015","journal-title":"Iubmb Life"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/dbio.2002.0812","article-title":"The Regulation and Action of Myostatin as a Negative Regulator of Muscle Development during Avian Embryogenesis","volume":"251","author":"Amthor","year":"2002","journal-title":"Dev. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1101\/gad.454408","article-title":"Myostatin Promotes the Terminal Differentiation of Embryonic Muscle Progenitors","volume":"22","author":"Manceau","year":"2008","journal-title":"Genes Dev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"40735","DOI":"10.1074\/jbc.M206379200","article-title":"The Myostatin Propeptide and the Follistatin-Related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Serum","volume":"277","author":"Hill","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(199907)180:1<1::AID-JCP1>3.0.CO;2-V","article-title":"Myostatin, a Transforming Growth Factor-\u03b2 Superfamily Member, Is Expressed in Heart Muscle and Is Upregulated in Cardiomyocytes after Infarct","volume":"180","author":"Sharma","year":"1999","journal-title":"J. Cell. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"14938","DOI":"10.1073\/pnas.95.25.14938","article-title":"Organization of the Human Myostatin Gene and Expression in Healthy Men and HIV-Infected Men with Muscle Wasting","volume":"95","author":"Taylor","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1096-4959(01)00350-5","article-title":"Sequence Conservation among Fish Myostatin Orthologues and the Characterization of Two Additional CDNA Clones from Morone Saxatilis and Morone Americana","volume":"129","author":"Rodgers","year":"2001","journal-title":"Comp. Biochem. Physiol. Bbiochem. Mol. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s003359900557","article-title":"Myostatin Maps to the Interval Containing the Bovine Mh Locus","volume":"8","author":"Smith","year":"1997","journal-title":"Mamm. Genome"},{"key":"ref_18","first-page":"229","article-title":"Muscle Fibre Type and Size, and Muscle Capillary Density in Young Double-Muscled Blue Belgian Cattle","volume":"41","author":"Stavaux","year":"1994","journal-title":"Zent. Vet. A"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1073\/pnas.151270098","article-title":"Regulation of Myostatin Activity and Muscle Growth","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08977190109029114","article-title":"GDF-8 Propeptide Binds to GDF-8 and Antagonizes Biological Activity by Inhibiting GDF-8 Receptor Binding","volume":"18","author":"Thies","year":"2001","journal-title":"Growth Factors"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15842","DOI":"10.1073\/pnas.2534946100","article-title":"Activation of Latent Myostatin by the BMP-1\/Tolloid Family of Metalloproteinases","volume":"100","author":"Wolfman","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lee, S.-J. (2008). Genetic Analysis of the Role of Proteolysis in the Activation of Latent Myostatin. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001628"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ydbio.2004.01.046","article-title":"Follistatin Complexes Myostatin and Antagonises Myostatin-Mediated Inhibition of Myogenesis","volume":"270","author":"Amthor","year":"2004","journal-title":"Dev. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1210\/me.2002-0366","article-title":"Regulation of Myostatin in Vivo by Growth and Differentiation Factor-Associated Serum Protein-1: A Novel Protein with Protease Inhibitor and Follistatin Domains","volume":"17","author":"Hill","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bbrc.2005.12.060","article-title":"Decorin Binds Myostatin and Modulates Its Activity to Muscle Cells","volume":"340","author":"Miura","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"25852","DOI":"10.1074\/jbc.M704146200","article-title":"Relationships between Transforming Growth Factor-\u03921, Myostatin, and Decorin Implications for Skeletal Muscle Fibrosis","volume":"282","author":"Zhu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1096\/fj.11-191189","article-title":"Cell-Type Specific Regulation of Myostatin Signaling","volume":"26","author":"Kemaladewi","year":"2012","journal-title":"FASEB J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1128\/MCB.23.20.7230-7242.2003","article-title":"Myostatin Signals through a Transforming Growth Factor \u03b2-Like Signaling Pathway To Block Adipogenesis","volume":"23","author":"Rebbapragada","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-Dependent and Smad-Independent Pathways in TGF-Beta Family Signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"49831","DOI":"10.1074\/jbc.M204291200","article-title":"Myostatin Inhibits Myoblast Differentiation by Down-Regulating MyoD Expression","volume":"277","author":"Langley","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"40235","DOI":"10.1074\/jbc.M004356200","article-title":"Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation","volume":"275","author":"Thomas","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/ng.2772","article-title":"BMP Signaling Controls Muscle Mass","volume":"45","author":"Sartori","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCRESAHA.115.304185","article-title":"Myostatin Regulates Energy Homeostasis in the Heart and Prevents Heart Failure","volume":"115","author":"Biesemann","year":"2014","journal-title":"Circ. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cellsig.2004.08.003","article-title":"Regulation of GDF-8 Signaling by the P38 MAPK","volume":"17","author":"Philip","year":"2005","journal-title":"Cell Signal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/gerona\/glr025","article-title":"Serum Concentrations of Myostatin and Myostatin-Interacting Proteins Do Not Differ between Young and Sarcopenic Elderly Men","volume":"66","author":"Ratkevicius","year":"2011","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00415-016-8379-6","article-title":"Reduced Serum Myostatin Concentrations Associated with Genetic Muscle Disease Progression","volume":"264","author":"Burch","year":"2017","journal-title":"J. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2012-1273","article-title":"Endocrine and Clinical Correlates of Myostatin Serum Concentration in Men--the STRAMBO Study","volume":"97","author":"Szulc","year":"2012","journal-title":"J. Clin. Endocrinol Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mce.2008.12.019","article-title":"Measurement of Myostatin Concentrations in Human Serum: Circulating Concentrations in Young and Older Men and Effects of Testosterone Administration","volume":"302","author":"Lakshman","year":"2009","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cmet.2016.05.023","article-title":"Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease","volume":"23","author":"Schafer","year":"2016","journal-title":"Cell Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1152\/japplphysiol.01616.2005","article-title":"Myogenic Gene Expression at Rest and after a Bout of Resistance Exercise in Young (18\u201330 Yr) and Old (80\u201389 Yr) Women","volume":"101","author":"Raue","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s12603-019-1255-1","article-title":"Serum Myostatin and IGF-1 as Gender-Specific Biomarkers of Frailty and Low Muscle Mass in Community-Dwelling Older Adults","volume":"23","author":"Chew","year":"2019","journal-title":"J. Nutr. Health Aging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12020-012-9836-3","article-title":"Prevalence of Cachexia in Chronic Heart Failure and Characteristics of Body Composition and Metabolic Status","volume":"43","author":"Christensen","year":"2013","journal-title":"Endocrine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/jcsm.12302","article-title":"Healthy Community-Living Older Men Differ from Women in Associations between Myostatin Levels and Skeletal Muscle Mass","volume":"9","author":"Peng","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"110869","DOI":"10.1016\/j.exger.2020.110869","article-title":"The Effects of Concurrent Training Order on Body Composition and Serum Concentrations of Follistatin, Myostatin and GDF11 in Sarcopenic Elderly Men","volume":"133","author":"Bagheri","year":"2020","journal-title":"Exp. Gerontol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/ijpvm.IJPVM_310_17","article-title":"Skeletal Muscle Hypertrophy, Insulin-like Growth Factor 1, Myostatin and Follistatin in Healthy and Sarcopenic Elderly Men: The Effect of Whole-Body Resistance Training","volume":"10","author":"Negaresh","year":"2019","journal-title":"Int. J. Prev. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.1069525","article-title":"Induction of Cachexia in Mice by Systemically Administered Myostatin","volume":"296","author":"Zimmers","year":"2002","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13539-010-0007-1","article-title":"Skeletal Muscle Wasting in Cachexia and Sarcopenia: Molecular Pathophysiology and Impact of Exercise Training","volume":"1","author":"Lenk","year":"2010","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2362.2006.01718.x","article-title":"Myostatin Expression in Ventricular Myocardium in a Rat Model of Volume-Overload Heart Failure","volume":"36","author":"Shyu","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/eurjhf\/hfp020","article-title":"Impact of Exercise Training on Myostatin Expression in the Myocardium and Skeletal Muscle in a Chronic Heart Failure Model","volume":"11","author":"Lenk","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1741826711402735","article-title":"Exercise Training Leads to a Reduction of Elevated Myostatin Levels in Patients with Chronic Heart Failure","volume":"19","author":"Lenk","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/eurjhf\/hfq039","article-title":"Myostatin Activation in Patients with Advanced Heart Failure and after Mechanical Unloading","volume":"12","author":"George","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurjhf\/hfr024","article-title":"Increased Plasma Myostatin in Heart Failure","volume":"13","author":"Gruson","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0300-8932(10)70212-8","article-title":"Serum Myostatin Levels in Chronic Heart Failure","volume":"63","author":"Zamora","year":"2010","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijcard.2016.06.231","article-title":"Serum Myostatin Levels Are Independently Associated with Skeletal Muscle Wasting in Patients with Heart Failure","volume":"220","author":"Furihata","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.cca.2012.04.023","article-title":"Plasma Myostatin Measured by a Competitive ELISA Using a Highly Specific Antiserum","volume":"413","author":"Wintgens","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2362.2008.01970.x","article-title":"Muscle Myostatin Signalling Is Enhanced in Experimental Cancer Cachexia","volume":"38","author":"Costelli","year":"2008","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"R716","DOI":"10.1152\/ajpregu.00121.2011","article-title":"Antibody-Directed Myostatin Inhibition Enhances Muscle Mass and Function in Tumor-Bearing Mice","volume":"301","author":"Murphy","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mce.2010.09.008","article-title":"Myostatin Up-Regulation Is Associated with the Skeletal Muscle Response to Hypoxic Stimuli","volume":"332","author":"Hayot","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1165\/rcmb.2008-0382OC","article-title":"Cellular Markers of Muscle Atrophy in Chronic Obstructive Pulmonary Disease","volume":"42","author":"Plant","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.rmed.2011.07.016","article-title":"Serum Myostatin Levels and Skeletal Muscle Wasting in Chronic Obstructive Pulmonary Disease","volume":"106","author":"Ju","year":"2012","journal-title":"Respir. Med."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Avin, K.G., Chen, N.X., Organ, J.M., Zarse, C., O\u2019Neill, K., Conway, R.G., Konrad, R.J., Bacallao, R.L., Allen, M.R., and Moe, S.M. (2016). Skeletal Muscle Regeneration and Oxidative Stress Are Altered in Chronic Kidney Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159411"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1096\/fj.03-1228fje","article-title":"Disuse Atrophy and Exercise Rehabilitation in Humans Profoundly Affects the Expression of Genes Associated with the Regulation of Skeletal Muscle Mass","volume":"18","author":"Jones","year":"2004","journal-title":"FASEB J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"E1110","DOI":"10.1152\/ajpendo.00464.2004","article-title":"Impact of Resistance Loading on Myostatin Expression and Cell Cycle Regulation in Young and Older Men and Women","volume":"288","author":"Kim","year":"2005","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1152\/japplphysiol.00679.2007","article-title":"Time Course of Proteolytic, Cytokine, and Myostatin Gene Expression after Acute Exercise in Human Skeletal Muscle","volume":"103","author":"Louis","year":"2007","journal-title":"J. Appl. Physiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1249\/MSS.0b013e3181e0b9a8","article-title":"Myostatin Decreases with Aerobic Exercise and Associates with Insulin Resistance","volume":"42","author":"Hittel","year":"2010","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0006-291X(02)02953-4","article-title":"Inhibition of Myostatin in Adult Mice Increases Skeletal Muscle Mass and Strength","volume":"300","author":"Whittemore","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Smith, R.C., Cramer, M.S., Mitchell, P.J., Lucchesi, J., Ortega, A.M., Livingston, E.W., Ballard, D., Zhang, L., Hanson, J., and Barton, K. (2020). Inhibition of Myostatin Prevents Microgravity-Induced Loss of Skeletal Muscle Mass and Strength. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0230818"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Pirruccello-Straub, M., Jackson, J., Wawersik, S., Webster, M.T., Salta, L., Long, K., McConaughy, W., Capili, A., Boston, C., and Carven, G.J. (2018). Blocking Extracellular Activation of Myostatin as a Strategy for Treating Muscle Wasting. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-20524-9"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1073\/pnas.1525795113","article-title":"Anti-Myostatin Antibody Increases Muscle Mass and Strength and Improves Insulin Sensitivity in Old Mice","volume":"113","author":"Camporez","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/s41598-021-81669-8","article-title":"Novel Myostatin-Specific Antibody Enhances Muscle Strength in Muscle Disease Models","volume":"11","author":"Muramatsu","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13395-017-0141-y","article-title":"A Mouse Anti-Myostatin Antibody Increases Muscle Mass and Improves Muscle Strength and Contractility in the Mdx Mouse Model of Duchenne Muscular Dystrophy and Its Humanized Equivalent, Domagrozumab (PF-06252616), Increases Muscle Volume in Cynomolgus Monkeys","volume":"7","author":"Johnson","year":"2017","journal-title":"Skelet. Muscle"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature01154","article-title":"Functional Improvement of Dystrophic Muscle by Myostatin Blockade","volume":"420","author":"Bogdanovich","year":"2002","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/mus.20920","article-title":"Myostatin Blockade Improves Function but Not Histopathology in a Murine Model of Limb-Girdle Muscular Dystrophy 2C","volume":"37","author":"Bogdanovich","year":"2008","journal-title":"Muscle Nerve"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2353\/ajpath.2006.051316","article-title":"Age-Dependent Effect of Myostatin Blockade on Disease Severity in a Murine Model of Limb-Girdle Muscular Dystrophy","volume":"168","author":"Parsons","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.2353\/ajpath.2010.090932","article-title":"Antibody-Directed Myostatin Inhibition Improves Diaphragm Pathology in Young but Not Adult Dystrophic Mdx Mice","volume":"176","author":"Murphy","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/jcsm.12438","article-title":"Inhibition of Myostatin Improves Muscle Atrophy in Oculopharyngeal Muscular Dystrophy (OPMD)","volume":"10","author":"Harish","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/hmg\/ddx431","article-title":"Myostatin Inhibition Using MRK35 Produces Skeletal Muscle Growth and Tubular Aggregate Formation in Wild Type and TgACTA1D286G Nemaline Myopathy Mice","volume":"27","author":"Tinklenberg","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41417-020-0178-7","article-title":"Improvement of Muscular Atrophy by AAV-SaCas9-Mediated Myostatin Gene Editing in Aged Mice","volume":"27","author":"Weng","year":"2020","journal-title":"Cancer Gene"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.nbd.2006.05.009","article-title":"Myostatin Inhibition Slows Muscle Atrophy in Rodent Models of Amyotrophic Lateral Sclerosis","volume":"23","author":"Holzbaur","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fphys.2020.00184","article-title":"Inhibition of Myostatin Reduces Collagen Deposition in a Mouse Model of Oculopharyngeal Muscular Dystrophy (OPMD) With Established Disease","volume":"11","author":"Harish","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Latres, E., Pangilinan, J., Miloscio, L., Bauerlein, R., Na, E., Potocky, T.B., Huang, Y., Eckersdorff, M., Rafique, A., and Mastaitis, J. (2015). Myostatin Blockade with a Fully Human Monoclonal Antibody Induces Muscle Hypertrophy and Reverses Muscle Atrophy in Young and Aged Mice. Skelet Muscle, 5.","DOI":"10.1186\/s13395-015-0060-8"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/cts.12420","article-title":"Translational Pharmacokinetic\/Pharmacodynamic Analysis of MYO-029 Antibody for Muscular Dystrophy","volume":"9","author":"Singh","year":"2016","journal-title":"Clin. Transl. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1096\/fj.04-2796com","article-title":"Myostatin Propeptide-Mediated Amelioration of Dystrophic Pathophysiology","volume":"19","author":"Bogdanovich","year":"2005","journal-title":"FASEB J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/hum.2007.159","article-title":"Myostatin Propeptide Gene Delivery by Adeno-Associated Virus Serotype 8 Vectors Enhances Muscle Growth and Ameliorates Dystrophic Phenotypes in Mdx Mice","volume":"19","author":"Qiao","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.gt.3302928","article-title":"AAV-Mediated Delivery of a Mutated Myostatin Propeptide Ameliorates Calpain 3 but Not \u03b1 -Sarcoglycan Deficiency","volume":"14","author":"Bartoli","year":"2007","journal-title":"Gene Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/ijo.2009.162","article-title":"The Effects of a Soluble Activin Type IIB Receptor on Obesity and Insulin Sensitivity","volume":"33","author":"Akpan","year":"2009","journal-title":"Int. J. Obes."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/gerona\/glt030","article-title":"Increased Muscle Force Production and Bone Mineral Density in ActRIIB-Fc-Treated Mature Rodents","volume":"68","author":"Chiu","year":"2013","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1152\/japplphysiol.00866.2009","article-title":"Administration of a Soluble Activin Type IIB Receptor Promotes Skeletal Muscle Growth Independent of Fiber Type","volume":"109","author":"Cadena","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajpath.2010.10.035","article-title":"Inhibition of Activin Receptor Type IIB Increases Strength and Lifespan in Myotubularin-Deficient Mice","volume":"178","author":"Lawlor","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"E539","DOI":"10.1152\/ajpendo.00370.2015","article-title":"Mitochondrial Impairment Induced by Postnatal ActRIIB Blockade Does Not Alter Function and Energy Status in Exercising Mouse Glycolytic Muscle in Vivo","volume":"310","author":"Pecchi","year":"2016","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/mt.2014.90","article-title":"Blockade of ActRIIB Signaling Triggers Muscle Fatigability and Metabolic Myopathy","volume":"22","author":"Relizani","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"FSO308","DOI":"10.4155\/fsoa-2018-0002","article-title":"Electrical Impedance Myography as a Biomarker of Myostatin Inhibition with ActRIIB-MFc: A Study in Wild-Type Mice","volume":"4","author":"Nagy","year":"2018","journal-title":"Future Sci. OA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1089\/hum.2012.056","article-title":"Combined Effect of AAV-U7-Induced Dystrophin Exon Skipping and Soluble Activin Type IIB Receptor in Mdx Mice","volume":"23","author":"Hoogaars","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/mus.26306","article-title":"Activin Type IIB Receptor Blockade Does Not Limit Adenosine Triphosphate Supply in Mouse Skeletal Muscle in Vivo","volume":"58","author":"Pecchi","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"115036","DOI":"10.1016\/j.bone.2019.115036","article-title":"Novel ActRIIB Ligand Trap Increases Muscle Mass and Improves Bone Geometry in a Mouse Model of Severe Osteogenesis Imperfecta","volume":"128","author":"Tauer","year":"2019","journal-title":"Bone"},{"key":"ref_97","first-page":"3957","article-title":"Inhibition of Myostatin Reverses Muscle Fibrosis through Apoptosis","volume":"125","author":"Li","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ajpath.2010.11.071","article-title":"Targeting the Activin Type IIB Receptor to Improve Muscle Mass and Function in the Mdx Mouse Model of Duchenne Muscular Dystrophy","volume":"178","author":"Pistilli","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13395-018-0180-z","article-title":"Myostatin and Activin Blockade by Engineered Follistatin Results in Hypertrophy and Improves Dystrophic Pathology in Mdx Mouse More than Myostatin Blockade Alone","volume":"8","author":"Iskenderian","year":"2018","journal-title":"Skelet. Muscle"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1152\/ajpendo.00065.2013","article-title":"Exercise Restores Decreased Physical Activity Levels and Increases Markers of Autophagy and Oxidative Capacity in Myostatin\/Activin-Blocked Mdx Mice","volume":"305","author":"Hulmi","year":"2013","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ajpath.2016.02.008","article-title":"Treatment with ActRIIB-MFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy","volume":"186","author":"Tinklenberg","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.ajpath.2014.03.003","article-title":"Differential Muscle Hypertrophy Is Associated with Satellite Cell Numbers and Akt Pathway Activation Following Activin Type IIB Receptor Inhibition in Mtm1 p.R69C Mice","volume":"184","author":"Lawlor","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"14275","DOI":"10.1038\/s41598-017-14290-3","article-title":"Myostatin Inhibition Prevents Skeletal Muscle Pathophysiology in Huntington\u2019s Disease Mice","volume":"7","author":"Bondulich","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1093\/hmg\/ddv288","article-title":"Muscle Hypertrophy Induced by Myostatin Inhibition Accelerates Degeneration in Dysferlinopathy","volume":"24","author":"Lee","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1172\/JCI28520","article-title":"Muscular Atrophy of Caveolin-3\u2013Deficient Mice Is Rescued by Myostatin Inhibition","volume":"116","author":"Ohsawa","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/MCB.01307-13","article-title":"An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy","volume":"34","author":"Minetti","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.1073\/pnas.1707925114","article-title":"Blockade of Activin Type II Receptors with a Dual Anti-ActRIIA\/IIB Antibody Is Critical to Promote Maximal Skeletal Muscle Hypertrophy","volume":"114","author":"Morvan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.0709144105","article-title":"Long-Term Enhancement of Skeletal Muscle Mass and Strength by Single Gene Administration of Myostatin Inhibitors","volume":"105","author":"Haidet","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.1073\/pnas.0609411103","article-title":"Gene Transfer Demonstrates That Muscle Is Not a Primary Target for Non-Cell-Autonomous Toxicity in Familial Amyotrophic Lateral Sclerosis","volume":"103","author":"Miller","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"6ra15","DOI":"10.1126\/scitranslmed.3000112","article-title":"Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates","volume":"1","author":"Kota","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-47818-w","article-title":"Follistatin-Based Ligand Trap ACE-083 Induces Localized Hypertrophy of Skeletal Muscle with Functional Improvement in Models of Neuromuscular Disease","volume":"9","author":"Pearsall","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_112","first-page":"435","article-title":"Follistatin-288-Fc Fusion Protein Promotes Localized Growth of Skeletal Muscle","volume":"365","author":"Castonguay","year":"2018","journal-title":"J. Pharm. Exp."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/rej.2008.0815","article-title":"Adeno-Associated Virus-8-Mediated Intravenous Transfer of Myostatin Propeptide Leads to Systemic Functional Improvements of Slow but Not Fast Muscle","volume":"12","author":"Foster","year":"2009","journal-title":"Rejuvenation Res."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Liu, M., Hammers, D.W., Barton, E.R., and Sweeney, H.L. (2016). Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166803"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/mus.21743","article-title":"Activin IIB Receptor Blockade Attenuates Dystrophic Pathology in a Mouse Model of Duchenne Muscular Dystrophy","volume":"42","author":"Morine","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Morine, K.J., Bish, L.T., Pendrak, K., Sleeper, M.M., Barton, E.R., and Sweeney, H.L. (2010). Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009176"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Hammers, D.W., Hart, C.C., Patsalos, A., Matheny, M.K., Wright, L.A., Nagy, L., and Sweeney, H.L. (2020). Glucocorticoids Counteract Hypertrophic Effects of Myostatin Inhibition in Dystrophic Muscle. JCI Insight, 5.","DOI":"10.1172\/jci.insight.133276"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1089\/hum.2011.102","article-title":"Long-Term Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Golden Retriever Muscular Dystrophy","volume":"22","author":"Bish","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.omtn.2016.11.009","article-title":"Systemic Antisense Therapeutics for Dystrophin and Myostatin Exon Splice Modulation Improve Muscle Pathology of Adult Mdx Mice","volume":"6","author":"Malerba","year":"2017","journal-title":"Mol. Nucleic Acids"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/mt.2009.322","article-title":"Combination of Myostatin Pathway Interference and Dystrophin Rescue Enhances Tetanic and Specific Force in Dystrophic Mdx Mice","volume":"18","author":"Dumonceaux","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1152\/japplphysiol.00126.2006","article-title":"Contractile Properties of EDL and Soleus Muscles of Myostatin-Deficient Mice","volume":"101","author":"Mendias","year":"2006","journal-title":"J. Appl. Physiol. (1985)"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1096\/fj.11-192195","article-title":"Is Functional Hypertrophy and Specific Force Coupled with the Addition of Myonuclei at the Single Muscle Fiber Level?","volume":"26","author":"Qaisar","year":"2011","journal-title":"FASEB J."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1073\/pnas.0604893104","article-title":"Lack of Myostatin Results in Excessive Muscle Growth but Impaired Force Generation","volume":"104","author":"Amthor","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mus.20175","article-title":"Loss of Myostatin Expression Alters Fiber-Type Distribution and Expression of Myosin Heavy Chain Isoforms in Slow- and Fast-Type Skeletal Muscle","volume":"31","author":"Girgenrath","year":"2005","journal-title":"Muscle Nerve"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"C525","DOI":"10.1152\/ajpcell.00259.2007","article-title":"Myostatin Regulates Fiber-Type Composition of Skeletal Muscle by Regulating MEF2 and MyoD Gene Expression","volume":"296","author":"Hennebry","year":"2009","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/JOE-17-0032","article-title":"IGF1 Stimulates Greater Muscle Hypertrophy in the Absence of Myostatin in Male Mice","volume":"234","author":"Hennebry","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10974-010-9214-9","article-title":"Myostatin Knockout Mice Increase Oxidative Muscle Phenotype as an Adaptive Response to Exercise","volume":"31","author":"Matsakas","year":"2010","journal-title":"J. Muscle Res. Cell Motil."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"E150","DOI":"10.1152\/ajpendo.00216.2016","article-title":"Myostatin Propeptide Mutation of the Hypermuscular Compact Mice Decreases the Formation of Myostatin and Improves Insulin Sensitivity","volume":"312","author":"Kocsis","year":"2016","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ana.10385","article-title":"Loss of Myostatin Attenuates Severity of Muscular Dystrophy in Mdx Mice","volume":"52","author":"Wagner","year":"2002","journal-title":"Ann. Neurol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1073\/pnas.0408729102","article-title":"Muscle Regeneration in the Prolonged Absence of Myostatin","volume":"102","author":"Wagner","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9440(10)62271-7","article-title":"Elimination of Myostatin Does Not Combat Muscular Dystrophy in Dy Mice but Increases Postnatal Lethality","volume":"166","author":"Li","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/352536a0","article-title":"The Mdx Mouse Diaphragm Reproduces the Degenerative Changes of Duchenne Muscular Dystrophy","volume":"352","author":"Stedman","year":"1991","journal-title":"Nature"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/hmg\/ddy382","article-title":"Specific Inhibition of Myostatin Activation Is Beneficial in Mouse Models of SMA Therapy","volume":"28","author":"Long","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1089\/neu.2015.4058","article-title":"A Soluble Activin Receptor IIB Fails to Prevent Muscle Atrophy in a Mouse Model of Spinal Cord Injury","volume":"33","author":"Graham","year":"2016","journal-title":"J. Neurotrauma"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1152\/ajpregu.00138.2009","article-title":"Pretreatment with a Soluble Activin Type IIB Receptor\/Fc Fusion Protein Improves Hypoxia-Induced Muscle Dysfunction","volume":"298","author":"Pistilli","year":"2010","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1210\/endo.142.8.8319","article-title":"Human Follistatin-Related Protein: A Structural Homologue of Follistatin with Nuclear Localization","volume":"142","author":"Tortoriello","year":"2001","journal-title":"Endocrinology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1096\/fj.07-8673com","article-title":"Transgenic Expression of a Myostatin Inhibitor Derived from Follistatin Increases Skeletal Muscle Mass and Ameliorates Dystrophic Pathology in Mdx Mice","volume":"22","author":"Nakatani","year":"2008","journal-title":"FASEB J."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/jpet.118.248195","article-title":"Protein Engineering on Human Recombinant Follistatin: Enhancing Pharmacokinetic Characteristics for Therapeutic Application","volume":"366","author":"Shen","year":"2018","journal-title":"J. Pharm. Exp."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1038\/mtna.2012.54","article-title":"Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-Penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular Dystrophy","volume":"1","author":"Malerba","year":"2012","journal-title":"Mol. Nucleic. Acids"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/genetics\/147.2.755","article-title":"Inheritance and Mapping of Compact (Cmpt), a New Mutation Causing Hypermuscularity in Mice","volume":"147","author":"Varga","year":"1997","journal-title":"Genetics"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2337\/db08-0245","article-title":"Loss-of-Function Mutation in Myostatin Reduces Tumor Necrosis Factor Alpha Production and Protects Liver against Obesity-Induced Insulin Resistance","volume":"58","author":"Wilkes","year":"2009","journal-title":"Diabetes"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1113\/JP279943","article-title":"Myostatin Inhibition Promotes Fast Fibre Hypertrophy but Causes Loss of AMP-Activated Protein Kinase Signalling and Poor Exercise Tolerance in a Model of Limb-Girdle Muscular Dystrophy R1\/2A","volume":"598","author":"Kramerova","year":"2020","journal-title":"J. Physiol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1096\/fj.201600271RR","article-title":"ActRIIB Blockade Increases Force-Generating Capacity and Preserves Energy Supply in Exercising Mdx Mouse Muscle in Vivo","volume":"30","author":"Pecchi","year":"2016","journal-title":"FASEB J."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/mus.21944","article-title":"Soluble Activin Receptor Type IIB Increased Forward Pulling Tension in the Mdx Mouse","volume":"43","author":"Carlson","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref_145","first-page":"R601","article-title":"Skeletal Muscle Myostatin mRNA Expression Is Fiber-Type Specific and Increases during Hindlimb Unloading","volume":"277","author":"Carlson","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-510X(87)90219-X","article-title":"Muscular Dystrophy in the Mdx Mouse: Histopathology of the Soleus and Extensor Digitorum Longus Muscles","volume":"80","author":"Carnwath","year":"1987","journal-title":"J. Neurol. Sci."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Bloemberg, D., and Quadrilatero, J. (2012). Rapid Determination of Myosin Heavy Chain Expression in Rat, Mouse, and Human Skeletal Muscle Using Multicolor Immunofluorescence Analysis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035273"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1113\/jphysiol.2014.287144","article-title":"Changes in Skeletal Muscle and Tendon Structure and Function Following Genetic Inactivation of Myostatin in Rats","volume":"593","author":"Mendias","year":"2015","journal-title":"J. Physiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ajmg.1320250407","article-title":"Small-Caliber Skeletal Muscle Fibers Do Not Suffer Deleterious Consequences of Dystrophic Gene Expression","volume":"25","author":"Karpati","year":"1986","journal-title":"Am. J. Med. Genet."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin Protects the Sarcolemma from Stresses Developed during Muscle Contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/FJC.0b013e3181e74a14","article-title":"Energy Metabolic Phenotype of the Cardiomyocyte during Development, Differentiation, and Postnatal Maturation","volume":"56","author":"Lopaschuk","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/thx.2003.009894","article-title":"Respiratory Muscle Fibres: Specialisation and Plasticity","volume":"59","author":"Polla","year":"2004","journal-title":"Thorax"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mus.24641","article-title":"Analysis of Muscle Fiber Clustering in the Diaphragm Muscle of Sarcopenic Mice","volume":"52","author":"Greising","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.21338","article-title":"A Phase I\/IItrial of MYO-029 in Adult Subjects with Muscular Dystrophy","volume":"63","author":"Wagner","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cpdd.386","article-title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF-06252616), an Antimyostatin Monoclonal Antibody, in Healthy Subjects","volume":"7","author":"Bhattacharya","year":"2018","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nmd.2020.05.002","article-title":"Randomized Phase 2 Trial and Open-Label Extension of Domagrozumab in Duchenne Muscular Dystrophy","volume":"30","author":"Wagner","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1200\/jco.2012.30.15_suppl.2516","article-title":"Safety of the Antimyostatin Monoclonal Antibody LY2495655 in Healthy Subjects and Patients with Advanced Cancer","volume":"30","author":"Jameson","year":"2012","journal-title":"JCO"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jcsm.12331","article-title":"LY2495655, an Antimyostatin Antibody, in Pancreatic Cancer: A Randomized, Phase 2 Trial: LY2495655 in Patients with Stage II-IV Pancreatic Cancer","volume":"9","author":"Golan","year":"2018","journal-title":"J. Cachexiasarcopenia Muscle"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"Myostatin Antibody (LY2495655) in Older Weak Fallers: A Proof-of-Concept, Randomised, Phase 2 Trial","volume":"3","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_160","first-page":"62","article-title":"A Phase 2 Randomized Study Investigating the Efficacy and Safety of Myostatin Antibody LY2495655 versus Placebo in Patients Undergoing Elective Total Hip Arthroplasty","volume":"5","author":"Woodhouse","year":"2016","journal-title":"J. Frailty Aging"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mus.23539","article-title":"A Single Ascending-Dose Study of Muscle Regulator Ace-031 in Healthy Volunteers","volume":"47","author":"Attie","year":"2013","journal-title":"Muscle Nerve"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/SPC.0000000000000013","article-title":"Myostatin Inhibitors as Therapies for Muscle Wasting Associated with Cancer and Other Disorders","volume":"7","author":"Smith","year":"2013","journal-title":"Curr. Opin. Support. Palliat Care"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/mus.25268","article-title":"Myostatin Inhibitor ACE-031 Treatment of Ambulatory Boys with Duchenne Muscular Dystrophy: Results of a Randomized, Placebo-Controlled Clinical Trial","volume":"55","author":"Campbell","year":"2017","journal-title":"Muscle Nerve"},{"key":"ref_164","unstructured":"(2019, October 20). Acceleron Discontinues Development of Phase 1 Molecule ACE-2494. 4 April 2019. Available online: http:\/\/investor.acceleronpharma.com\/news-releases\/news-release-details\/acceleron-discontinues-development-phase-1-molecule-ace-2494."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/mus.26113","article-title":"Locally Acting ACE-083 Increases Muscle Volume in Healthy Volunteers","volume":"57","author":"Glasser","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"P1.6-062","DOI":"10.1212\/WNL.92.15_supplement.P1.6-062","article-title":"A Phase 1b\/2 Study of the Anti-Myostatin Adnectin RG6206 (BMS-986089) in Ambulatory Boys with Duchenne Muscular Dystrophy: A 72-Week Treatment Update (P1.6-062)","volume":"92","author":"Wagner","year":"2018","journal-title":"Neurology"},{"key":"ref_167","unstructured":"(2021, January 13). Roche\/Genentech Announces Decision to Discontinue Development of RG6206 (RO7239361). Available online: https:\/\/www.parentprojectmd.org\/roche-genentech-announces-decision-to-discontinue-development-of-rg6206-ro7239361\/."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1212\/WNL.0000000000001070","article-title":"Treatment of Sporadic Inclusion Body Myositis with Bimagrumab","volume":"83","author":"Amato","year":"2014","journal-title":"Neurology"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"S38.003","DOI":"10.1212\/WNL.90.15_supplement.S38.003","article-title":"Long-Term Efficacy and Safety of Bimagrumab in Inclusion Body Myositis: 2 Years Results (S38.003)","volume":"90","author":"Amato","year":"2018","journal-title":"Neurology"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Amato, A.A., Hanna, M.G., Machado, P.M., Badrising, U.A., Chinoy, H., Benveniste, O., Karanam, A.K., Wu, M., Tank\u00f3, L.B., and Schubert-Tennigkeit, A.A. (2021). Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-Term Extension of RESILIENT. Neurology.","DOI":"10.1212\/WNL.0000000000011626"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e2020836","DOI":"10.1001\/jamanetworkopen.2020.20836","article-title":"Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial","volume":"3","author":"Rooks","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jgs.14927","article-title":"Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study","volume":"65","author":"Rooks","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/jcsm.12205","article-title":"Effect of Bimagrumab on Thigh Muscle Volume and Composition in Men with Casting-induced Atrophy","volume":"8","author":"Rooks","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1164\/rccm.201802-0286OC","article-title":"Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial","volume":"199","author":"Polkey","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/mt.2014.200","article-title":"A Phase 1\/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy","volume":"23","author":"Mendell","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ymthe.2017.02.015","article-title":"Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes","volume":"25","author":"Mendell","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"E1967","DOI":"10.1210\/jc.2014-1271","article-title":"Pharmacological Inhibition of Myostatin and Changes in Lean Body Mass and Lower Extremity Muscle Size in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer","volume":"99","author":"Padhi","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41467-017-01486-4","article-title":"Downregulation of Myostatin Pathway in Neuromuscular Diseases May Explain Challenges of Anti-Myostatin Therapeutic Approaches","volume":"8","author":"Mariot","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1006\/bbrc.1999.0213","article-title":"Early Decrease of IIx Myosin Heavy Chain Transcripts in Duchenne Muscular Dystrophy","volume":"255","author":"Pedemonte","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/wdev.230","article-title":"Skeletal Muscle Fiber Type: Using Insights from Muscle Developmental Biology to Dissect Targets for Susceptibility and Resistance to Muscle Disease","volume":"5","author":"Talbot","year":"2016","journal-title":"Wiley Interdiscip Rev. Dev. Biol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0092-8674(88)90463-1","article-title":"Fast Muscle Fibers Are Preferentially Affected in Duchenne Muscular Dystrophy","volume":"52","author":"Webster","year":"1988","journal-title":"Cell"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Rybalka, E., Timpani, C.A., Debruin, D.A., Bagaric, R.M., Campelj, D.G., and Hayes, A. (2020). The Failed Clinical Story of Myostatin Inhibitors against Duchenne Muscular Dystrophy: Exploring the Biology behind the Battle. Cells, 9.","DOI":"10.20944\/preprints202010.0234.v1"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and Efficacy of Eculizumab in Anti-Acetylcholine Receptor Antibody-Positive Refractory Generalised Myasthenia Gravis (REGAIN): A Phase 3, Randomised, Double-Blind, Placebo-Controlled, Multicentre Study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_184","first-page":"3091","article-title":"Functional Muscle Recovery Following Dystrophin and Myostatin Exon Splice Modulation in Aged Mdx Mice","volume":"28","author":"Ferry","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/dom.13042","article-title":"Bimagrumab Improves Body Composition and Insulin Sensitivity in Insulin-Resistant Individuals","volume":"20","author":"Garito","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e2033457","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw. Open"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/3\/533\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:31:52Z","timestamp":1760160712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/3\/533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":186,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["cells10030533"],"URL":"https:\/\/doi.org\/10.3390\/cells10030533","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]}}}